Rigel to Participate in Upcoming September Investor Conferences
Rigel Pharmaceuticals (RIGL) will participate in three investor conferences in New York in September 2026, featuring its chief financial officer, Dean Schorno.
Rhea-AI Summary
Rigel Pharmaceuticals (RIGL) will participate in three investor conferences in New York in September 2026, featuring its chief financial officer, Dean Schorno. The company will join Citi's 2026 Biopharma Back to School Conference for one-on-one meetings on September 9. It will hold one-on-one meetings and present a company overview at the Cantor Global Healthcare Conference 2026 on September 10 at 11:30 a.m. ET, and at the H.C. Wainwright 28th Annual Global Investment Conference on September 15 at 10:00 a.m. ET. Live and archived webcasts for the Cantor and H.C. Wainwright presentations will be available via the Investor Relations section of www.rigel.com.
Positive
- None.
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 13 | Product availability | Positive | -2.6% | VEPPANU availability announced for eligible patients with advanced breast cancer |
| Aug 04 | Earnings report | Positive | +4.6% | Second-quarter results included revenue growth and raised 2026 outlook |
| Jul 28 | Earnings scheduling | Neutral | +3.0% | Company scheduled second-quarter results call and webcast for August 4 |
| Jul 07 | Equity grants | Negative | +5.7% | Company granted restricted stock units to six new non-executive employees |
| Jul 01 | Leadership change | Positive | -2.1% | Alison L. Hannah appointed chief medical officer effective July 1, 2026 |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Rigel's prior general-news reactions were mixed and more often diverged from headline sentiment, with four divergence events versus one alignment.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- Citi's 2026 Biopharma Back to School Conference in
New York, NY
Rigel will participate in one-on-one meetings on Wednesday, September 9. - Cantor Global Healthcare Conference 2026 in
New York, NY
Rigel will participate in one-on-one meetings and present a company overview on Thursday, September 10, at 11:30 a.m. ET. - H.C. Wainwright 28th Annual Global Investment Conference in
New York, NY
Rigel will participate in one-on-one meetings and present a company overview on Tuesday, September 15, at 10:00 a.m. ET.
To access the live webcasts or archived recordings of the Cantor and H.C. Wainwright conference presentations, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.
About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.
Contact for Investors & Media:
Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
ir@rigel.com
Media:
David Rosen
Argot Partners
646.461.6387
david.rosen@argotpartners.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-to-participate-in-upcoming-september-investor-conferences-302866936.html
SOURCE Rigel Pharmaceuticals, Inc.